Latest Clene Nanomedicine News & Updates

See the latest news and media coverage for Clene. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Clene Nanomedicine (Clene)

Clinical-stage biopharmaceutical company developing nanotherapeutics for neurodegenerative diseases

clene.com
Headquarters
SALT LAKE CITY, United States
Founded year
2013
Company type
Public company
Number of employees
70–200

Latest news about Clene Nanomedicine (Clene)

Company announcements

  • Clene

    Clene reports full year 2025 financial results

    Announces FDA Type C meeting, oversubscribed $28M offering, and CNM-Au8 ALS progress. Cash runway extends to Q3 2026.

  • Clene

    Clene issues stockholder letter highlighting CNM-Au8 2026 catalysts

    Outlines sufficient capital into Q4 2026, upcoming FDA Type C meeting, NDA submission in Q2 2026, and potential PDUFA in H2 2026.

  • Clene

    Clene announces CNM-Au8 biomarker data

    FDA grants in-person Type C meeting in Q1 2026. New analyses link NfL reductions to lower ALS mortality risk, supporting NDA filing. IGFBP7 decline associates with 78% reduced mortality.

  • Clene

    Clene announces registered direct offering of over $28 million

    Oversubscribed offering priced above market to new, existing, and insider investors provides initial $6M into Q3 2026, with $22M contingent on FDA NDA milestones.

Unlock all announcements with a

Media coverage

  • Investing.com

    Clene Inc. ten percent owner Ugwumba sells $119,889 in stock By Investing.com

    Clene Inc. ten percent owner Ugwumba sells $119,889 in stock...

  • Investing.com

    Clene Inc. ten percent owner sells $99k in shares

    In other recent news, Clene Inc. has made significant strides in its efforts to advance its ALS treatment, CNM-Au8. The company announced it will have...

  • Morningstar

    Clene Inc Ordinary Shares CLNN

    Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive...

  • Minichart

    Clene Inc. 2025 Annual Report Highlights: Financial Performance, Risk Factors, and Future Outlook – Minichart

    Clene Inc. 2025 Annual Report: Key Highlights for Investors Clene Inc. 2025 Annual Report: Key Highlights for Investors Ticker: CLNN Exchange: Nasdaq Capital Market Fiscal...

Unlock all articles with a

Never miss news about Clene

Track Clene and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Clene competitors & trending companies

Browse news for competitors to Clene and other trending companies.